CliffBio
small molecule

ABLAVAR

GADOFOSVESET TRISODIUM

Loss of exclusivity—loss of exclusivity
CompanyLantheus Medical Imaging →See this company's full patent-cliff portfolio

Drug detail

Brand nameABLAVAR
Active ingredientGADOFOSVESET TRISODIUM
Strength2440MG/10ML (244MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalDecember 2008
Marketing statusDISCN

More from Lantheus Medical Imaging

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ABLAVAR patent cliff — loss of exclusivity — | CliffBio